Children with Down syndrome are up to 150 times more likely to develop acute myeloid leukemia before age 5 and yet very ...

I was diagnosed with acute myeloid leukemia, and the prognosis was not good. I was given just a few months to live. The only ...

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with ...

His mother, Patricia, is a former Southeastern Conference Associate Commissioner as well. Unfortunately, there is no cure for ...

The Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and developing FDA-approved treatments, ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly – the ...

Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Aptose Biosciences is advancing the development of its promising drug tuspetinib as part of a triplet therapy for acute myeloid leukemia (AML), showing strong clinical activity and a unique safety ...

for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Approval was based on results from the FELIX study, an open-label, multicenter, single-arm trial that enrolled ...